In June 2024, the US FDA approved Botanix Pharmaceutical's sofpironium (Sofdra) topical gel, 12.45% to treat primarily axillary hyperhidrosis in adults and children ages 9 and older. It is the first and only chemical entity approved for excessive underarm sweating.
Check out the Sofdra and Botanix websites for more details. Sofpironium bromide is designed as a structural analog of anticholinergic glycopyrrolate.
https://www.no-ets.com/sofdra-sofpironium-gel.html
https://www.sofdra.com/
https://botanixpharma.com/